Please assess the completion status of the following clinical trial:

Trial Title: Intensive Versus Regular Dosage For PD In AKI.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age older than 14 years;~* Be diagnosed as AKI according to KDIGO recommendation;~* Having indications for renal replacement therapy.~Exclusion Criteria:~* Having contraindications to peritoneal dialysis;~* Functional azotemia;~* Hypercatabolic status;~* Previous CKD history (baseline eGFR\<60ml/min/1.73m2 or proteinuria);~* Psychological disorder or communication barrier;~* Pregnancy;~* Refusing to receive dialysis therapy.~* receiving mechanical ventilation.

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention group (Type: EXPERIMENTAL): Intervention group is intensive dosage of PD.
- Control group (Type: ACTIVE_COMPARATOR): Control group is regular dosage of PD.

Based on this trial design, predict the completion outcome and termination type (if applicable).